High Expression of TIM 3 and Galectin 9 on Immunohistochemistry Staining of Tumor Specimen at Diagnosis in Pediatric Patients with Ewing Sarcoma

Significant progress has been made in the advancement of immune system modulation for cancer treatment in recent years. In particular, immune checkpoint inhibitors and chimeric antigen receptor (CAR) T-cell therapy have demonstrated remarkable clinical benefit in relapsed/refractory cancers. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Si, Stephanie J., Wertheim, Gerald B., Barrett, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351179/
https://www.ncbi.nlm.nih.gov/pubmed/35938052
http://dx.doi.org/10.33696/cancerimmunol.3.053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351179/
https://www.ncbi.nlm.nih.gov/pubmed/35938052
http://dx.doi.org/10.33696/cancerimmunol.3.053

Ejemplares similares